Photoinitiator TPO CAS 75980-60-8
Assay: ≥99%
Appearance: yellowish crystal or powder
Capacity: 100 MT per month
Packaging: 20 kg carton
Sample: available
related documents:
MSDS of Photoinitiator TPO
COA of Photoinitiator TPO
TDS of Photoinitiator TPO
Request for product documents
Table of Contents
- Product Overview
- Technical Specifications & Comparison
- Key Applications
- Usage Guidelines
- Industry Case Studies
- Contact for Technical Consultation
Photoinitiator TPO (CAS 75980-60-8) Overview
Critical Performance Advantages
TPO demonstrates 23% faster curing speed than conventional initiators while maintaining low volatility (VOC < 0.8%). Its non-yellowing properties ensure ΔE < 1.2 after 1000h UV exposure, making it ideal for optical-grade applications.
Technical Parameters & Competitive Analysis
| Parameter | TPO | TPO-L | Irgacure 184 |
|---|---|---|---|
| Absorption Range (nm) | 320-420 | 340-410 | 250-340 |
| Thermal Stability (°C) | 230 | 210 | 180 |
| Recommended Loading (%) | 1.5-3.0 | 2.0-4.0 | 3.0-5.0 |
Industrial Applications
UV-Curable Systems Optimization
Enables 35% faster line speeds in automotive clear coat production compared to benzophenone-based systems. Compatible with LED UV sources (385-405nm), reducing energy consumption by 40%.
Advanced Material Solutions
Enables formulation of low-odor dental composites with 98.6% monomer conversion rate. Critical component in 3D printing resins achieving <10μm layer resolution.
Formulation Best Practices
Optimal Usage Conditions
Recommended oxygen inhibition control: 0.1-0.3% amine synergist. Maximum film thickness: 250μm for 395nm LED curing (2J/cm² exposure).
Documented Success Cases
Case 1: Automotive OEM Coating Upgrade
Client: European Automotive Supplier
Challenge: Reduce curing energy costs while maintaining Class A surface finish
Solution: TPO-based formulation achieved 22% lower IR footprint with 50m/min conveyor speed
Result: €1.2M annual energy savings, VDA 6.1 compliance certified
Case 2: Medical Device Manufacturing
Client: US-based Catheter Producer
Challenge: Eliminate extractables in blood-contact devices
Solution: TPO-initiated silicone hydrogel with 99.8% conversion rate
Result: Passed ISO 10993-5 cytotoxicity requirements, 18-month shelf life achieved
Technical & Commercial Consultation
Request Customized Solutions
Contact our formulation experts for:
– Batch-specific technical data sheets
– Regulatory support (REACH, FDA 21 CFR)
– Trial quantities (1kg-25kg available)
Email: info@vivalr.com
Tel: (86) 15866781826
Ongoing Technical Support
Post-purchase services include:
– FTIR curing analysis reports
– DSC thermal stability testing
– On-site formulation troubleshooting



评论
目前还没有评论。